OpenVSafe by OpenVAERS
Search V-safe

YAE-78688-10291

3 vaccinations 22 coded responses 26 check-ins 21 free-text entries 7 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
028 / RI
Registered
2021-04-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-10
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-04-11
    Registered in v-safe
  3. 2021-04-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dyspnoea, Emotional disorder, Feeling abnormal — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Emotional, trouble breathing, brain fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Affective disorder, Anxiety — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Anxiety, black mood, terror
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Emotional disorder — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Emotional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-13
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Limb immobilisation, Mood swings — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Mood swings, difficulty moving left leh
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Emotional distress — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work
    Free text: Very emotional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-17
    Survey response — day 7, dose 1
    MedDRA: Affective disorder, Joint stiffness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Jaw clenching, flat mood
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-24
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Hypersomnia, Somnolence — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Still exhausted. Sleeping 12 hours a night.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-01
    Survey response — day 21, single dose
    MedDRA: Infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Infection in jaw
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-08
    Survey response — day 28, single dose
    MedDRA: Insomnia, Pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Insomnia, pain, frequent stool
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-08
    Report sent to call center — day 28, single dose
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-17
    Health check-in — day 35, single dose
    Feeling: Fair
    Adult check-in
  16. 2021-05-24
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  17. 2021-05-25
  18. 2021-07-10
    Survey response — 3 months, dose 1
    MedDRA: Fatigue, Headache, Oropharyngeal pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sore throat, fatigue, fever, headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-10-09
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  20. 2021-10-30
    Dose 2 — Janssen/Johnson & Johnson
  21. 2022-04-10
    Survey response — 12 months, dose 1
    MedDRA: Cervix carcinoma — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Cancerous cells on cervix
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-04-10
    Report sent to call center — 12 months, dose 1
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-04-12
  24. 2022-04-14
  25. 2022-04-29
    Call successful
    Participant prefers to complete VAERS report online
  26. 2022-05-02
  27. 2022-09-22
    Dose 3 — Pfizer-BioNTech
  28. 2022-09-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Anxiety, Headache, Hyperaesthesia — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Anxiety, headache, heightened senses
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-09-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Anxiety, Hypersensitivity, Insomnia — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Heightened senses, high anxiety, insomnia
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-09-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Anxiety, Constipation, Sensory disturbance — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Constipation, heightened senses except taste, anxiety
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-09-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Nightmare — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Nightmares
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-09-29
    Survey response — day 7, dose 3
    MedDRA: Anxiety, Nightmare — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Extreme anxiety, nightmares
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-10-13
    Survey response — day 21, dose 3
    MedDRA: Asthenia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Lack of rnergy
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-10-20
    Survey response — day 28, dose 3
    MedDRA: Vaginal disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Vaginal issues
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-10-20
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  36. 2022-10-21
  37. 2022-10-29
    Survey response — day 35, dose 3
    MedDRA: Fatigue, Memory impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Memory issues, crushing fatigue
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-10-29
    Report sent to call center — day 35, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-10-31
    Call successful
    Participant prefers to complete VAERS report online
  40. 2022-10-31
    Call successful
    Participant prefers to complete VAERS report online
  41. 2022-11-04
    Survey response — day 42, dose 3
    MedDRA: Depression, Fatigue, Liver function test abnormal, Memory impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Fatigue, depression, memory issues, liver test bad
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-11-04
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  43. 2022-11-07
    Call successful
    Participant prefers to complete VAERS report online
  44. 2022-12-22
    Survey response — 3 months, dose 3
    MedDRA: Depression, Fatigue, Gastrointestinal disorder, Headache, Hyperacusis, Pain in extremity, Vibratory sense increased — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Headaches, terrible fatigue, pain in left arm, digestive trouble, depression, acute hearing and sensitivity to vibrations
    MedDRA releases: 2024-11 · check-in free text available
  45. 2023-03-25
    Survey response — 6 months, dose 3
    MedDRA: Ear infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  46. 2023-03-25
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  47. 2023-03-27
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Janssen/Johnson & Johnson
22021-10-30Janssen/Johnson & Johnson No
32022-09-22Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-13 Successful
2021-05-08 Successful
2021-05-25
2022-04-10 Successful
2022-04-29
Participant prefers to complete VAERS report online
2022-10-20 Successful
2022-10-31
Participant prefers to complete VAERS report online
2022-10-29 Successful
2022-10-31
Participant prefers to complete VAERS report online
2022-11-04 Successful
2022-11-07
Participant prefers to complete VAERS report online
2023-03-25 Successful
2023-03-27
Completed over the phone

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-11

Systemic reaction (other): Emotional, trouble breathing, brain fog

2021-04-12

Systemic reaction (other): Anxiety, black mood, terror

2021-04-13

Systemic reaction (other): Emotional

2021-04-15

Systemic reaction (other): Mood swings, difficulty moving left leh

2021-04-16

Systemic reaction (other): Very emotional

Release 7 — day 7, dose 1

2021-04-17

Systemic reaction (other): Jaw clenching, flat mood

Release 7 — day 14, dose 1

2021-04-24

Symptoms: Still exhausted. Sleeping 12 hours a night.

Release 8 — day 21, single dose

2021-05-01

Symptoms: Infection in jaw

Release 8 — day 28, single dose

2021-05-08

Symptoms: Insomnia, pain, frequent stool

Release 9 — 3 months, dose 1

2021-07-10

Symptoms: Sore throat, fatigue, fever, headache

Release 11 — 12 months, dose 1

2022-04-10

Symptoms: Cancerous cells on cervix

Release 12 — days 1–6 daily, dose 3

2022-09-24

Systemic reaction (other): Anxiety, headache, heightened senses

2022-09-25

Systemic reaction (other): Heightened senses, high anxiety, insomnia

2022-09-26

Systemic reaction (other): Constipation, heightened senses except taste, anxiety

2022-09-27

Systemic reaction (other): Nightmares

Release 12 — day 7, dose 3

2022-09-29

Systemic reaction (other): Extreme anxiety, nightmares

Release 12 — day 21, dose 3

2022-10-13

Symptoms: Lack of rnergy

Release 12 — day 28, dose 3

2022-10-20

Symptoms: Vaginal issues

Release 12 — day 35, dose 3

2022-10-29

Symptoms: Memory issues, crushing fatigue

Release 12 — day 42, dose 3

2022-11-04

Symptoms: Fatigue, depression, memory issues, liver test bad

Release 12 — 3 months, dose 3

2022-12-22

Symptoms: Headaches, terrible fatigue, pain in left arm, digestive trouble, depression, acute hearing and sensitivity to vibrations

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia · · ✓
SDCervix carcinoma · · ✓
SDDepression · · ✓
SDEar infection · · ✓
SDFatigue ✓ ✓ ✓
SDGastrointestinal disorder · · ✓
SDHeadache ✓ ✓ ✓
SDHyperacusis · · ✓
SDHypersomnia · · ✓
SDInfection ✓ ✓ ✓
SDInsomnia ✓ ✓ ✓
SDLiver function test abnormal · · ✓
SDMemory impairment · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPain in extremity · · ✓
SDPyrexia ✓ ✓ ✓
SDSomnolence ✓ ✓ ○
SDVaginal disorder · · ✓
SDVibratory sense increased · · ✓
SROAffective disorder ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓
SROConstipation · · ✓
SRODyspnoea ✓ ✓ ✓
SROEmotional disorder ✓ ✓ ✓
SROEmotional distress ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROHeadache · · ✓
SROHyperaesthesia · · ✓
SROHypersensitivity · · ✓
SROInsomnia · · ✓
SROJoint stiffness ✓ ✓ ✓
SROLimb immobilisation ✓ ✓ ✓
SROMood swings ✓ ✓ ✓
SRONightmare · · ✓
SROSensory disturbance · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release